Himadri Speciality Chemical Q1 Net Profit Jumps 26.3% to ₹230 Crore; Approves ₹368 Crore Capex Push

Market snapshot: Himadri Speciality Chemical Ltd (HSCL) has reported a robust performance for Q1 FY27, marked by solid bottom-line growth and aggressive capital deployment. The company's consolidated net profit rose by 26.33% year-on-year to ₹229.52 crore on the back of healthy revenue growth. Alongside the earnings release, the board has approved a substantial capital expenditure plan of ₹368 crore to establish India's first Carbon Nano Tube facility and scale specialty carbon capacities.

Data Snapshot

• Consolidated Net Profit (PAT) rose by 26.33% YoY to ₹229.52 crore, up from ₹181.69 crore in the corresponding quarter last year.
• Consolidated Revenue from Operations stood at ₹1,431.88 crore, growing 28.04% YoY from ₹1,118.29 crore.
• Consolidated EBITDA increased 17.51% YoY to ₹287.90 crore from ₹245.00 crore, while the EBITDA margin contracted to 20.11% from 21.91% YoY.
• Approved a ₹368 crore capex plan containing ₹170 crore for Super Speciality Carbon Black, ₹70 crore for Carbon Nano Tubes, and ₹128 crore for capacity doubling of Anthraquinone and Carbazole.

What's Changed

• Consolidated Net profit grew by 26.33% YoY (derived: ₹229.52 crore vs ₹181.69 crore).
• Revenue from operations increased by 28.04% YoY (derived: ₹1,431.88 crore vs ₹1,118.29 crore).
• Operating profit margin (OPM) compressed to 20.11% from 21.91% YoY due to raw material input inflation.
• Capex map expanded with ₹368 crore in newly approved projects targeting higher-margin downstream chemical and advanced nanotechnology solutions.

Key Takeaways

• Top-line performance of 28.04% growth highlights sustained demand across Himadri's core carbon materials segments.
• The ₹70 crore investment to build India's first 200 MTPA Carbon Nano Tube (CNT) facility marks a crucial development step in battery-materials manufacturing.
• Doubling Anthraquinone and Carbazole capacities from 2,600 MTPA to 5,300 MTPA with a ₹128 crore outlay strengthens the niche specialty chemical portfolio.
• Input cost inflation acted as a minor drag, pulling the EBITDA margin down by 180 basis points YoY, though operating leverage partially absorbed the impact.

SAHI Perspective

Himadri's Q1 FY27 results reinforce its successful transition from an industrial chemical player to a specialized, high-margin advanced materials developer. While rising input prices marginally compressed EBITDA margins to 20.11%, the strong 26.33% net profit expansion demonstrates the underlying strength of the core business. The aggressive ₹368 crore capex program targets high-margin, specialized battery chemistry elements (CNTs and specialty carbon) which are essential components for EV gigafactories. This moves the company up the value chain from commodity carbon products.

Market Implications

By executing high-value capex, Himadri is structurally changing its long-term margin profile and building a moat in advanced battery technology. Its focus on specialized chemicals like Anthraquinone, Carbazole, and CNTs reduces reliance on commodity carbon black markets and aligns the company with structural domestic EV and clean energy demand, supporting positive valuation multiples over the medium term.

Trading Signals

Market Bias: Bullish

Strong top-line volume growth and an aggressive capex pivot into high-margin advanced materials support a positive outlook. Consolidated Q1 net profit of ₹229.52 crore reinforces solid operational momentum despite short-term margin contraction to 20.11%.

Overweight: Specialty Chemicals, Advanced Battery Materials

Underweight: Commodity Carbon Products

Trigger Factors:

• Timelines and execution of the ₹70 crore Carbon Nano Tube facility expected by Q4 FY27.
• Input raw material price trends, which currently exert pressure on operating margins.
• Commercial integration with International Battery Company (IBC) following the recent stake increase to 20.47%.

Time Horizon: Medium-term (3–12 months)

Industry Context

The global specialty chemicals and lithium-ion battery material supply chain is undergoing structural shifts toward regional security and localization. Himadri is capitalising on these shifts as one of the few integrated domestic manufacturers of critical battery components such as anode materials and CNTs in India, serving as a primary import-substitution play.

Key Risks to Watch

• Execution risks associated with bringing sophisticated advanced battery carbon and CNT facilities online on schedule.
• Potential volatility in key raw feedstocks (coal tar pitch, chemical raw materials) which could further compress margins.
• Foreign exchange risks associated with export realizations and imported inputs.

Recent Developments

In June 2026, Himadri Speciality Chemical raised its equity stake in US-headquartered International Battery Company (IBC) to 20.47% via an additional investment of USD 0.66 million, deepening downstream integration. In April 2026, the company successfully commissioned its first anode material production facility at Mahistikry, West Bengal, with an initial capacity of 200 MTPA.

Closing Insight

Himadri Speciality Chemical's robust Q1 FY27 earnings, combined with strategic capital expenditure into advanced carbon nanotechnologies, solidify its role as a key beneficiary of the global EV transition. Strategic investors should monitor commissioning milestones as indicators of long-term value creation.

High Performance Trading with SAHI.